IDO1 and neoplasm: A more recent example of an 18F-labeled tracer that is thought to preferentially target the KYN pathway is 1-(2-[18F]fluoroethyl)-tryptophan ([18F]FETrp, Figure 1), which accumulates in IDO1-expressing cells and IDO1-positive tumor xenografts [18,19].